cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2002; 40:1794-1800
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Logeart, D.
Right arrow Articles by Solal, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Logeart, D.
Right arrow Articles by Solal, A. C.

Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea

Damien Logeart, MD*,*, Carole Saudubray, MD*, Pascale Beyne, MD{dagger}, Gabriel Thabut, MD{ddagger}, Pierre-Vladimir Ennezat, MD*, Christophe Chavelas, MD*, Caroline Zanker, MD§, Erik Bouvier, MD* and Alain Cohen Solal, MD, PhD*

* Service de Cardiologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France
{dagger} Service de Biochimie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France
{ddagger} Service de Pneumologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France
§ Service d’Accueil des Urgences, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France



View larger version (15K):

[in a new window]
 
Figure 1 Box plots showing median levels of B-type natriuretic peptide (BNP) after logarithmic transformation. (A) Control groups (patients with chronic stable heart failure (HF); and patients with no HF or lung disease) and patients with acute dyspnea, according to the final diagnosis. *p < 0.001 between decompensated congestive left-heart failure (CHF) group and others groups. **p < 0.05 between non–HF group and "non–HF, non–lung disease" group. (B) Various subgroups of CHF and non–CHF patients, according to normal or abnormal left ventricular ejection fraction (LVEF). **p < 0.05.

 


View larger version (11K):

[in a new window]
 
Figure 2 Receiver-operating characteristics curve for B-type natriuretic peptide cutoff values. AUC = area under the curve.

 


View larger version (18K):

[in a new window]
 
Figure 3 Diagnostic value of B-type natriuretic peptide (BNP) and Doppler mitral pattern for decompensated congestive left-heart failure (CHF) in 43 patients with BNP levels between 80 and 300 pg/ml.

 


View larger version (22K):

[in a new window]
 
Figure 4 Algorithm for the etiologic diagnosis of acute dyspnea, based on B-type natriuretic peptide (BNP) assay and Doppler echocardiography. CHF = decompensated congestive left-heart failure; ECG = electrocardiogram.

 




 
  cardiology careers collections past issues search home